-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ET8AhlG4fvR003Llq/Br/z5lukvAeBH3e7lD06tofhqbXlWMNIoku9mvg96Q3Esx nSPH+BR+1WUYtOY6RzQltQ== 0001209191-10-031528.txt : 20100602 0001209191-10-031528.hdr.sgml : 20100602 20100602150745 ACCESSION NUMBER: 0001209191-10-031528 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100528 FILED AS OF DATE: 20100602 DATE AS OF CHANGE: 20100602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gillespie Deirdre CENTRAL INDEX KEY: 0001354737 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 10872598 MAIL ADDRESS: STREET 1: 416 MARLBOROUGH STREET STREET 2: APT. 707 CITY: BOSTON STATE: MA ZIP: 02115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-05-28 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001354737 Gillespie Deirdre 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 1 1 0 0 President & CEO Stock Option (right to buy) 0.06 2010-05-28 4 A 0 4000000 0.00 A 2020-05-28 Common Stock 4000000 4000000 D The stock options vest and become exercisable monthly over the next three years. /s/ Deirdre Y. Gillespie 2010-06-02 -----END PRIVACY-ENHANCED MESSAGE-----